Jason L. Vassy, MD, MPH

Adjunct Assistant Professor, Medicine

Jason Vassy
617.638.5300
150 S Huntington Avenue

Other Positions

  • VA Boston Healthcare System

Education

  • Washington University School of Medicine, MD
  • Johns Hopkins University School of Public Health, MPH
  • Furman University, BS
  • Harvard School of Public Health, SM/ScM

Publications

  • Published on 10/27/2021

    Dong OM, Roberts MC, Wu RR, Voils CI, Sperber N, Gavin KL, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Chapman JG, Voora D. Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites. Pharmacogenomics. 2021 Oct 27. PMID: 34704830.

    Read at: PubMed
  • Published on 7/1/2021

    Brunette CA, Vassy JL. The role of SLCO1B1 genotyping in lowering cardiovascular risk. Pharmacogenomics. 2021 07; 22(11):649-656. PMID: 34196599.

    Read at: PubMed
  • Published on 5/1/2021

    Tian L, Vassy JL, Ritchie CS, Lee CC, Kim DH. How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19. Ann Intern Med. 2021 05; 174(5):731-732. PMID: 33999681.

    Read at: PubMed
  • Published on 3/1/2021

    Ho YL, Nguyen XT, Yan JQ, Vassy JL, Gagnon DR, Gaziano JM, Wilson PW, Cho K, Djoussé L. Chocolate consumption and risk of coronary artery disease: the Million Veteran Program. Am J Clin Nutr. 2021 05; 113(5):1137-1144. PMID: 34483344.

    Read at: PubMed
  • Published on 1/6/2021

    Dong OM, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Meyer LJ, Icardi M, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Jacobitz R, Rozelle S, Chapman JG, Voora D. Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program. Pharmacogenomics. 2021 02; 22(3):137-144. PMID: 33403869.

    Read at: PubMed
  • Published on 12/1/2020

    Vassy JL, Gaziano JM, Green RC, Ferguson RE, Advani S, Miller SJ, Chun S, Hage AK, Seo SJ, Majahalme N, MacMullen L, Zimolzak AJ, Brunette CA. Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial. JAMA Netw Open. 2020 12 01; 3(12):e2027092. PMID: 33270123.

    Read at: PubMed
  • Published on 10/6/2020

    Smetana GW, Vassy JL, Hofstatter E, Libman H. Should You Recommend Direct-to-Consumer Genetic Testing for This Patient? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2020 10 06; 173(7):563-571. PMID: 33017547.

    Read at: PubMed
  • Published on 10/1/2020

    Hull LE, Vassy JL, Stone A, Chanfreau-Coffinier CC, Heise CW, Pratt VM, Przygodzki R, Voils CI, Voora D, Wang-Rodriguez J, Schichman SA, Scheuner MT. Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System. J Mol Diagn. 2020 10; 22(10):1264-1271. PMID: 32980074.

    Read at: PubMed
  • Published on 8/31/2020

    Raghavan S, Ho YL, Vassy JL, Posner D, Honerlaw J, Costa L, Phillips LS, Gagnon DR, Wilson PWF, Cho K. Optimizing Atherosclerotic Cardiovascular Disease Risk Estimation for Veterans With Diabetes Mellitus. Circ Cardiovasc Qual Outcomes. 2020 Aug 31; CIRCOUTCOMES120006528. PMID: 32862698.

    Read at: PubMed
  • Published on 7/7/2020

    Orkaby AR, Driver JA, Ho YL, Lu B, Costa L, Honerlaw J, Galloway A, Vassy JL, Forman DE, Gaziano JM, Gagnon DR, Wilson PWF, Cho K, Djousse L. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older. JAMA. 2020 07 07; 324(1):68-78. PMID: 32633800.

    Read at: PubMed

View 67 more publications: View full profile at BUMC

View all profiles